Hong Li

Dr. Hong Li


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2015 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
SCShan Chen
Shan Chen
ZLZongchang Li
Zongchang Li
YHYing He
Ying He
FZFengyu Zhang
Fengyu Zhang
HLHong Li
Hong Li
JTJinsong Tang
Jinsong Tang
Several lines of evidence indicate mitochondrial impairment in the pathophysiology of autism. As one of the most common biomarkers for mitochondrial dysfunction, mitochondrial DNA (mtDNA) copy number has also been linked to autism, but the relationship between mtDNA copy number and autism was still obscured. In this study, we performed a case–control study to investigate whether mtDNA copy number in peripheral blood cells is related to patients with autism. Relative mtDNA copy number in peripheral blood cells was measured by using real-time polymerase chain reaction method. The participants in this study included 78 patients with childhood autism and 83 typically developing children. We observed children with autism had significantly elevated relative mtDNA copy number than healthy controls (Beta = −0.173, P = 0.0003). However, there were no significant correlations between mtDNA copy number and clinical features (paternal age, maternal age, age of onset, illness of duration, CARS score and ABC score) in childhood autism. We show that elevated mtDNA copy number in peripheral blood is associated with autism, indicating that there may be mitochondrial dysfunction in children with autism.

29 June 2023 in Journal of Affective Disorders
Verified
Journal Article
Closed access
HLHong Li
Hong Li
LHLingzhi Hou
Lingzhi Hou
DWDong Wang
Dong Wang
QWQijin Wu
Qijin Wu
HLHaijin Li
Haijin Li
JCJun Cheng
Jun Cheng

19 September 2024 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
HLHaijin Li
Haijin Li
JGJu Gao
Ju Gao
HSHuihui Song
Huihui Song
XYXuna Yang
Xuna Yang
CLCai Li
Cai Li
HLHong Li
Hong Li
Aims: The study aimed to assess brain metabolite differences in the medial prefrontal cortex (mPFC) between acute and euthymic episodes of bipolar disorder (BD) with both mania and depression over a 6‐month medication treatment period.Methods: We utilized 1H‐MRS technology to assess the metabolite levels in 53 individuals with BD (32 in depressive phase, 21 in manic phase) and 34 healthy controls (HCs) at baseline. After 6 months of medication treatment, 40 subjects underwent a follow‐up scan in euthymic state. Metabolite levels, including N‐acetyl aspartate (NAA), glutamate (Glu), and Glutamine (Gln), were measured in the mPFC.Results: Patients experiencing depressive and manic episodes exhibited a notable reduction in NAA/Cr + PCr ratios at baseline compared to healthy controls (p = 0.004; p = 0.006) in baseline, compared with HCs. Over the 6‐month follow‐up period, the manic group displayed a significant decrease in Gln/Cr + PCr compared to the initial acute phase (p = 0.03). No significant alterations were found in depressed group between baseline and follow‐up.Conclusion: This study suggests that NAA/Cr + PCr ratios and Gln/Cr + PCr ratios in the mPFC may be associated with manic and depressive episodes, implicating that Gln and NAA might be useful biomarkers for distinguishing mood phases in BD and elucidating its mechanisms.

29 August 2026 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
YLYitong Liu
Yitong Liu
YZYue Zhang
Yue Zhang
CLCai Li
Cai Li
YXYan Xu
Yan Xu
YXYiwen Xuan
Yiwen Xuan
DWDong Wang
Dong Wang
Overlapping clinical features and the absence of objective diagnostic markers frequently lead to the misdiagnosis of adolescent bipolar disorder (BD) as ma

16 May 2026 in BMC Psychiatry
Verified
Journal Article
Open access
JWJiahui Wang
Jiahui Wang
LHLingzhi Hou
Lingzhi Hou
CLCai Li
Cai Li
YLYitong Liu
Yitong Liu
YXYan Xu
Yan Xu
HLHong Li
Hong Li
Immune dysregulation and cognitive deficits are increasingly recognized in adolescent major depressive disorder (MDD), yet their interrelationship remains unclear. This study aimed to investigate peripheral immune-inflammatory alterations and natural killer (NK) cell phenotypes, and explore their association with cognitive function in adolescent MDD. Fifty-four first-episode, drug-naïve adolescents with MDD and 33 matched healthy controls (HCs) were enrolled. Group differences in peripheral blood immune-inflammatory indices (NLR, PLR, MLR, SII, SIRI), NK cell surface receptors (HLA-DR, NKp46, NKp30, NKG2A, NKG2C, KIR2DL1, ILT2, CD57), and cognitive function were analyzed, along with their intercorrelations. Compared with HCs, patients with MDD showed lower NEU, NLR, PLR, and SII levels, alongside elevated LYM counts. NK cells exhibited reduced overall proportions but increased expression of HLA-DR, NKp46, NKG2A, and ILT2, with decreased CD57 expression in the MDD group. Significant cognitive impairments were observed in speed of processing, reasoning and problem solving, and social cognition. Exploratory analyses suggested potential links between immune measures and cognitive performance, which require confirmation in larger samples. The observed immune and cognitive alterations warrant further investigation into potential neuroimmune mechanisms in adolescent MDD. This study provides novel insight into potential biomarkers and immunomodulatory targets for early intervention in adolescent MDD. Not applicable.